Filing Flows › Retractable Technologies (RVP) › Q4 2025
Retractable Technologies (RVP) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 27, 2026
Retractable Technologies (RVP) reported revenue of $9.4M for the fourth quarter 2025 (Q4 2025), +4% from a year earlier and -6% from the quarter before. Operating margin was -81.7%, net loss $2.3M (24.9% of revenue).
Retractable Technologies, Q4 2025: revenue $9.4M (+4% year over year), operating margin -81.7%, net loss $2.3M, operating cash flow −$597K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.4M | -6% | +4% |
| Operating profit | −$7.7M | — | — |
| Net earnings | −$2.3M | -733% | -162% |
| Operating cash flow | −$597K | — | — |
What changed
Revenue was $9.4M in Q4 2025, up 4% year over year and down 6% from the previous quarter. Syringes was the largest line at 65% of revenue.
Operating costs exceeded revenue by $7.7M, an operating margin of -81.7%. Total costs grew 5% against revenue growth of 4%. The fastest-growing cost line was Sales & marketing (+66%). The quarter ended with a net loss of $2.3M, after a profit of $371K the previous quarter. Non-operating items added $5.4M, -229% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$597K. Non-cash charges added back $2.1M of depreciation and amortization. Working capital and other items used $393K.
Questions
What was Retractable Technologies' revenue in the fourth quarter 2025?
Retractable Technologies (RVP) reported revenue of $9.4M for the fourth quarter 2025 (Q4 2025), +4% from a year earlier and -6% from the quarter before.
Was Retractable Technologies profitable in the fourth quarter 2025?
Operating loss was $7.7M (-81.7% of revenue) and net loss $2.3M.